Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

Pfizer is looking to rise the terms of its COVID-19 vaccines successful the United States by up to 4 times erstwhile Washington’s acquisition programme ends, according to the company’s U.S. president, Angela Lukin. Pfizer’s COVID-19 vaccine is presently provided escaped for each Americans by the U.S. government. Next year, erstwhile the U.S. nationalist wellness exigency expires, the COVID-19 vaccine marketplace volition determination to backstage insuranc...